News
Alveo Technologies Partners with Alliance Global (AGBL) to Expand Access to Avian Influenza Testing Across Africa, Central Asia and a Portion of the Eastern Mediterranean
As outbreaks accelerate worldwide, the agreement brings Alveo’s rapid, on-farm molecular diagnostic testing to farmers and health officials on three continents ALAMEDA, Calif. – September, 2026 – Alveo Technologies, Inc., a global leader in rapid, point-of-need molecular diagnostics for early disease detection, today announced a distribution agreement with Alliance Global